Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY Study: Combined Facial Treatment with BOTOX, JUVÉDERM, and LATISSE
NCT02176356Phase 4Completed
- Sponsor
- Allergan
- Start
- Jun 2014
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA, bimatoprost in facial rhytides, sponsored by Allergan. Started Jun 2014; status: completed.
02
Drugs
onabotulinumtoxinAbimatoprost
03
Conditions
facial rhytides
Beyond the preview
Go deeper on NCT02176356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176356.